|
WO2016019149A1
|
|
Mitochondrial dna mutation profile for predicting human health conditions and disease risk and for monitoring treatments
|
|
US2015011478A1
|
|
Cmv gene products promote cancer stem cell growth
|
|
AU2014233198A1
|
|
Falz for use as a target for therapies to treat cancer
|
|
AU2013318095A1
|
|
miR-18b for use as a marker of cancer progression and target for therapies to treat cancer
|
|
US2013209483A1
|
|
Resorcinol derivatives
|
|
US2007093432A1
|
|
Camptothecin derivatives as chemoradiosensitizing agents
|
|
EP1691836A2
|
|
Anti-pecam therapy for metastasis suppression
|
|
AU2004264857A1
|
|
Remote detection of substance delivery to cells
|
